Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 4 (RPL21P4)

Target
RPL21P4
Molecular classification
Other (Pseudogene)
01

Overview

RPL21P4 (ribosomal protein L21 pseudogene 4) is a processed pseudogene located in the human genome. Pseudogenes like RPL21P4 are sequences that originated via retrotransposition or duplication of a functional ancestor (here, the ribosomal protein L21 gene), but have since lost their protein-coding capacity due to disabling mutations or lack of regulatory sequences. RPL21P4 does not encode a functional protein and is considered non-coding; it has no known function, biological activity, or value as a drug target. Pseudogenes of ribosomal proteins are common and distributed throughout the human genome; the RPL21 gene itself has numerous associated pseudogenes, but only the functional RPL21 encodes a component of the ribosomal 60S subunit involved in protein synthesis. There are currently no known disease, biomarker, or drug associations with RPL21P4. If your focus is on potential therapeutic targets or functional gene products, you likely want to consult the functional gene "Ribosomal protein L21" (abbreviation RPL21), not RPL21P4.

Other names
RPL21_58_1548RPL21P4Ribosomal protein L21 pseudogene 4
02

Mechanism of action

None.

03

Biological functions

None (as a pseudogene, RPL21P4 does not have biological function; pseudogenes generally lack the ability to encode functional proteins)
04

Disease associations

None known; there are no established disease associations for the pseudogene RPL21P4 itself
05

Safety considerations

None.
06

Interacting drugs

None known.
07

Biomarkers

None.

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 4 (RPL21P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 4 (RPL21P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call